References
- Bryan JP, Rucha H, Scheld WM. Problems in Salmonellosis: rationale for clinical trials with newer beta-lactams and quinolones. Rev Infect Dis 1986; 8: 189–207.
- Goldstein FW, Chumpitaz JC, Guevara JM, Papadopolou B, Acar JF, Viess JF. Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi. J Infect Dis 1986; 153: 261–266.
- Chin NX, Neu H. Ciprofloxacin, a quinolone carboxylic compound active against aerobic and anaerobic bacteria. Antimicrob Agents Chemother 1984; 25: 319–26.
- Aukenthaler R, Michea-Hamzehpour M, Pechere JC. In vitro activity of newer quinolones against aerobic bacteria. J Antimicrob Chemother 1986; 17 (Suppl. B): 29–30.
- Hannan A. In vitro activity of ofloxacin against 210 clinical isolates with typhoid Salmonella. Infection 1986; 14 (Suppl. 4): S 243–S 244.
- Mandai B, Flegg P, Dunbar E, Whale K, Brennand J. Ciprofloxacin in enteric fever. Chemioterapia 1987; 6 (Suppl. 2): 492–3.
- Eykyn SJ, Williams H. Treatment of multiresistant Salmonella typhi with oral ciprofloxacin. Lancet 1987; 2 (8572): 1407–1408.
- Standley PJ, Flegg PJ, Mandai BK, Geddes AM. Open study of ciprofloxacin in enteric fever. J Antimicrob Chemother 1989; 23: 789–791.
- Hajji M, El Mdaghri N, Benbachir M, El Filali KM, Himmich H. Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever. Eur J Clin Microbiol Infect Dis 1988; 7: 361–3.
- Stahl JP, Leclercq P, Croize J, et al. Traitment des fievres typhoides par ofloxacine. Experience clinique et determination de la diffusion ganglion nairre messentique de l’antibiotique. Pathol Biol 1986; 34: 505–7.
- Cristiano P, Leonessa V, Morelli B, Briante V, Paradisi F, Altucci P. Clinical experience with ofloxacin (DL 8280) in the therapy of various infections. Preliminary report. Infection 1986; 14 (Suppl. 4): PS 307–8.
- Tanhaichitra D, Sahaphong S, Srimuang S. Ofloxacin, a new quinolone in the treatment of genitourinary and enteric infections. Infection 1986; (Suppl. 4): PS 321–3.
- Lo WL. Ofloxacin in treatment of typhoid fever: a preliminary study. J Antimicrob Chemother 1988; 21: 681–2.
- Wang F, Gu XJ, Zhang MF, Tai TY. Treatment of typhoid fever with ofloxacin. J Antimicrob Chemother 1989; 23: 785–788.
- Velmonte MA, Montalban CS. Norfloxacin in the treatment of infections caused by Salmonella typi. Scand J Infect Dis 1988; 56 (Suppl.): 46–48.
- Gotuzzo E, Guerra J, Benavente L, et al. Use of norfloxacin to treat chronic typhoid carriers. J Infect Dis 1988; 157: 1221–1225.
- Ferraccio C, Morris JG Jr, Valdivieso C, Prenzel I, Sotomayor V, Drusano GL, Levine MM. Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers. J Infect Dis 1988; 157: 1235–9.
- Cristiano P, Morelli G. Therapeutic role of fluroquinolones in the therapy of typhoid fever. Western Pacific Congress Inf. Dis. Chemotherapy. Kuala Lampur, 1989 abs OR 9/6.
- Tanphaichitra D, Srimuang S. In vitro and clinical evaluation of ofloxacin in urinary tract infection and enteric fever. Int Congr. Infect. Dis. Rio De Janairo, 1988. abs 186.
- Kazmierczak A, Pechinot A, Duez JM, Haaso, Favre JP. Biliary tract excretion of ofloxacin in man. Drugs 1987; 34 (Suppl. 1): 39–43.